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A. Alape-Giron, B. G. Stiles and J. M. Gutitrrez. Antibody-mediated neutral- 
ization and binding-reversal studies on u-neurotoxins from Micrurus nigrocinc- 
tus nigrocinctus (coral snake) venom. Toxicon 34, 369-380, 1996.-An ELISA 
based, non-radioactive acetylcholine receptor (AchR) binding assay was used 
to detect the u-neurotoxins present in Micrurus nigrocinctus nigrocinctus 
venom. Sera from horses hyperimmunized against M. nigrocinctus venom 
contain antibodies which inhibit the binding of M. n. nigrocinctus u-neurotox- 
ins to AchR and reverse the binding of toxins already complexed with the 
receptor. This result supports the importance of using antivenom therapeuti- 
cally in M. n. nigrocinctus envenomations even after the onset of neurological 
symptoms. 
M. nigrocinctus antivenoms cross-reacted in an ELISA with several elapid 
a-neurotoxins and inhibited the binding of Bungarus multicinctus cr-bungaro- 
toxin and Naja naja oxiana neurotoxin II to AchR in vitro, suggesting the 
presence of short-chain and long-chain a-neurotoxins in M. nigrocinctus 
venom. In vivo neutralization experiments with M. nigrocinctus antivenom 
demonstrate that M. nigrocinctus venom contains short-chain a-neurotoxin(s) 
which share common neutralizing epitope(s) with Naja naja oxiana neurotoxin 
II. 
INTRODUCTION 
Snakes belonging to the genus Micrurus (New World coral snakes) are widely distributed 
from the Southeastern United States to Argentina (Campbell and Lamar, 1989). Neverthe- 
less, Micrurus venoms have been poorly characterized, relative to other elapid venoms, 
because of the difficulty of maintaining the snakes as well as low venom yields. 
Micrurus nigrocinctus nigrocinctus is the most abundant and medically important coral 
snake in Central America (Bolaiios, 1984). Clinical and experimental studies indicate that 
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its venom has several pharmacological activities (Bolafios, 1984; Gutierrez et al., 1980; Tan 
and Ponnudurai, 1990). The mouse LD,, of M. n. nigrocinctus venom is 0.765 mg/kg i.p. 
(intraperitoneally) and 2 mg/kg subcutaneously (Gutitrrez et al., 1991). This venom 
induces paralysis and respiratory failure in animals (Jimenez-Porras, 1968) and electro- 
physiological changes in vitro that suggest the presence of postsynaptic and presynaptic 
toxins (Goularte et al., 1995). When injected intramuscularly in mice, M. n. nigrocinctus 
venom is myonecrotic, but does not elicit edema or hemorrhage (Gutitrrez et al., 
1980,1986). 
Therapeutic actions after Micrurus envenomations include administration of im- 
munoglobulins from horses hyperimmunized against Micrurus venoms (Bolafios, 1984; 
Russell, 1983; Kitchens and Van Mierop, 1987; Coelho et al., 1993). Recently, an equine 
M. nigrocinctus antivenom was reported to neutralize the PLA, activity, as well as the 
myotoxicity and lethality of this venom (Gutierrez et al., 1991; Lomonte et al., 1993). This 
antivenom also contains antibodies which cross-react with a-neurotoxins and neurotoxic 
phospholipases from other elapid venoms (Alape-Giron et al., 1994a,b). 
Snake venom a-neurotoxins are basic, low molecular weight proteins that prevent the 
binding of acetylcholine to nicotinic acetylcholine receptor (AchR) at the neuromuscular 
endplate (Karlsson, 1979). The binding of an a-neurotoxin to AchR paralyses striated 
muscles, including the diaphragm, and produces death of envenomated animals by 
respiratory failure (Chang, 1979). The LD,,s of a-neurotoxins, when injected intravenously 
in mice, range between 0.05 and 0.15 mg/kg (Karlsson, 1979). More than 85 a -neurotoxins 
have been isolated from elapid venoms and their amino acid sequences elucidated. The 
secondary and tertiary structures of several a-neurotoxins are known from spectroscopic 
studies and X-ray analysis (Endo and Tamiya, 1991). According to the polypeptide chain 
length, a-neurotoxins are classified into two types: “short-chain” toxins (mol. wt z 7000) 
consist of 60-62 amino acids and four invariant disulfide bonds, while “long-chain” toxins 
(mol. wt x 8000) contain 70-74 amino acids and five disulfide bonds (Karlsson, 1979). 
Both toxin types bind to AchR with very high affinities (dissociation constants range from 
IO-” to lo-“). Despite structural similarities, differences exist between the two types of 
a-neurotoxins regarding biophysical and antigenic characteristics (Karlsson, 1979; Boquet, 
1979). The short-chain and long-chain a-neurotoxins are immunologically distinct 
(Boquet, 1979). Cross-reactivity and cross-neutralization have been reported only among 
toxins within the same toxin type (Tremeau, et al., 1986; Charpentier et al., 1990; Menez, 
1991). 
The purpose of this study was three-fold: (1) determine if M. n. nigrocinctus venom 
contains a-neurotoxins; (2) evaluate the ability of therapeutic M. nigrocinctus antivenom 
to inhibit and reverse the binding of homologous a-neurotoxins to AchR; and (3) 
determine if M. nigrocinctus antivenom contains neutralizing antibodies against heter- 
ologous short-chain and/or long-chain a-neurotoxins. 
MATERIALS AND METHODS 
Venoms and toxins 
A pool of M. n. nigrocinctus venom was obtained from more than 100 specimens collected in the central plateau 
region of Costa Rica and kept at the serpentarium of lnstituto Clodomiro Picado (San JOG. Costa Rica). Venom 
was lyophilized and stored at -20°C. Purified Laticauda semifasciata erabutoxin b, Naja naju atru a-cobrotoxin 
and Naja nuja oxiana neurotoxin I (NT I) were obtained from Ventoxin (Frederick, MD, U.S.A.). Nuja naju 
kaouthia a-cobratoxin, Bungarus multicinctus a-bungarotoxin and Naja naja oxiana neurotoxin II (NT II) were 
purchased from Sigma Chemical Co. (St. Louis, MO, U.S.A.). 
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M. nigrocinctus antivenoms 
Monovalent antisera against M. nigrocinctus venom were produced in two horses (11 and 26) according to 
an immunization schedule already described (Bolaiios and Cerdas, 1980). After the first immunization protocol, 
horses were boosted with 20 mg of venom every 60 days. Following the 9th boost, serum samples were obtained 
at days 28 and 50. A 10th venom injection was given at day 60, after which serum samples were also taken at 
days lo,31 and 56. Five equine M. nigrocinctus antivenoms (batches 196, 198,207,221 and 232), were produced 
at the Instituto Clodomiro Picado between 1989 and 1993. 
Preparation of acetylcholine receptor (AchR) 
AchR from the electric organ of Torpedo callfornica (Pacific Biomarine, Venice, CA1 U.S.A.) was purified as 
described (Froenher and Rafto, 1979). Briefly, frozen electric organ tissue (300 g) was minced at 4°C in a Waring 
blender with 250ml of 10mM Tris-HCl, pH 7.4, 1~mM NaCl. 0.5 mM sodium azide (Buffer A). The 
homogenate was filtered through sterile cheesecloth and the filtrate centrifuged at 26,000g for 45 min. The pellet 
was extracted with the above buffer containing 1% Triton X-100 (Buffer B) for 2 hr at 4°C. 
After centrifugation, the supernatant was incubated overnight at 4°C with 15mg of Naja naja kaouthiu 
a-cobratoxin covalently bound to 15 ml of packed agarose beads (Sigma). The beads were then serially washed 
with Buffer B, Buffer B plus 1 M NaCl, and finally Buffer A containing 0.1% Triton X-100. AchR was eluted 
from the beads using Buffer A containing 0.1% Triton X- 100 and 1 M carbamylcholine chloride. Afhnity-purified 
receptor was dialyzed at 4°C against Buffer A containing 0.1% Triton X-100 and stored in sterile glycerol (33% 
final concentration) at -70°C. All materials used to purify AchR were autoclaved or rinsed in 70% ethanol and 
the buffers contained I mM EDTA, 1 mM EGTA, and 0.1 mM phenylmethylsulfonyl fluoride to inhibit protease 
activity. 
Antiserum to AchR 
Guinea-pigs were each immunized i.p. with 5Opg of purified AchR in 2OOpg of Ribi Adjuvant (Hamilton, 
MT, U.S.A.) every 2 weeks. After three injections, the animals were bled and sera pooled and frozen at - 20°C. 
AchR binding assays 
The AchR binding assays (Stiles, 1991) were performed as follows: each well of Immulon II microtiter plates 
(Dynatech, McClean, VA, U.S.A.) was coated overnight at 4°C with 1 pg of purified a-neurotoxins diluted in 
100 ~10.05 M carbonate buffer (pH 9.6). Doseeresponse studies were done by coating wells with varying amounts 
of M. n. nigrocinctus venom (0.1620 pg) diluted in carbonate buffer. The remaining binding sites were blocked 
for 30 min at 37°C with 300 ~1 of phosphate-buffered saline (PBS), pH 7.4, containing 1% gelatin (PBSG). After 
aspiration, 100 ~1 of AchR (50 u&ml), diluted in PBS containing 0.1% Tween 20, and 0.1% gelatin (PBSTG). 
was added. Negative controls in&d&l wells coated with toxin followed by 100~1 PBSTG wGhout AchR and 
wells without toxin which received 100 ~1 of the receptor preparation. After a I hr incubation at room 
temperature (r.t.), plates were washed three times with PBS containing 0.1% Tween 20 (PBST) and 100 pl of 
a 1: 200 PBSTG dilution of guinea-pig anti-AchR was added per well. Following a I hr incubation at r.t. and 
four washes with PBST, lOOfl1 of a PBSTG dilution of goat anti-guinea pig IgG conjugated to alkaline 
phosphatase (Sigma) was added per well. After an additional 1 hr incubation at r.t. and five washes with PBST, 
150 ~1 of para-nitrophenyl phosphate substrate solution (1 mg/ml) (Kirkegaard and Perry Laboratories, 
Gaithersburg, MD, U.S.A.) diluted in diethanolamine buffer, pH 9.8 was added per well. Absorbances were read 
at 405 nm after 30 min. The competitive assay was done by mixing varying amounts of N. n. nigrocincrus venom 
(0.16-20 L(R) with 5 tig of AchR in 100 til of PBSTG. The mixture was incubated 20min at r.t. and annlied to 
wells coated with N; n. oxiana NT II. All other steps were identical to the non-competitive assay as described 
before. The absorbance readings for 5 fig venom/well were within the linear portion of a dose-response curve 
and thus used for in vitro neutralization studies. 
For inhibition experiments the adsorbed venom or toxin was incubated with serum samples diluted in PBSG 
for I hr at 37°C before the addition of AchR in order to estimate the ability of antibodies to block the binding 
of toxins to AchR. For reversal binding studies, a 30 min incubation at r.t. with dihrted antisera was carried out 
after adding AchR to determine if the antibodies destabilize the AchR-toxin(s) complex(es). Subsequent steps 
were identical to the assay as described above. Results are expressed as a percentage, relative to the absorbances 
of wells incubated with PBSG instead of serum. The neutralizing activity of antivenom was expressed as an 
effective dilution 50% (ED&, and defined as the dilution at which the binding was inhibited by 50%. 
Assay for proteoiytie activity 
Proteolytic activity was assayed using hide powder azure (Sigma) as substrate (Riderknecht ef al., 1968). Briefly, 
IO mg of hide powder azure was dissolved in 2.5 ml of Tris 0.05 M, pH 7.0 buffer, and incubated at 37’C for 
1 hr in the presence of varying amounts of M. n. nigrocinctus venom (0.042OOpg). After centrifugation. the 
absorbance was determined at 595 nm. Control tubes contained either E. asper venom and substrate or only 
substrate incubated with buffer. 
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Detection and titration of antibodies by ELISA 
Immulon II microtiter plates were coated overnight at 4°C with 1 pg of M. n. nigrocinctus venom or purified 
toxin/well using carbonate buffer as diluent. The remaining binding sites were blocked with 300 ~1 of PBSG for 
30 min at 37°C. After aspiration, 100 ~1 of each PBSTG diluted antivenom sample was added per well and 
incubated for 1 hr at 37°C. Negative controls on each plate consisted of non immune horse sera or a polyvalent 
Bothrops-Crotalus-Lachesis antivenom produced at the Instituto Clodomiro Picado. After five washes with 
PBST, 100~1 of PBSTG diluted goat anti-horse IgG alkaline phosphatase conjugate (Kirkegaard and Perry 
Laboratories) was added per well. After a 1 hr incubation at 37°C plates were washed five times with PBST, 
150 ~1 of para-nitrophenyl phosphate substrate solution (1 mg/ml) diluted in diethanolamine buffer, pH 9.8 was 
added per well, and absorbances read at 405 nm after 30 min. 
Neutralization studies 
A fixed amount of either M. n. nigrocinctus venom, B. nndticinctus a-bungarotoxin or N. n. oxiana NT II were 
incubated with varying amounts of M. nigrocinctus antivenom (batch 232) for 30 min at 37°C. Each mixture 
(0.5 ml), containing four LDSO of venom or toxin (corresponding to 3 pg of NT II and 10 pg of a-bungarotoxin) 
was injected i.p. into groups of four Swiss-Webster mice (1618 g body weight). Control groups received 4 LD~ 
of venom or toxin in PBS. The time to death was recorded over a 72 hr period and neutralization was expressed 
as effective dose 50% (ED~), defined as the volume of antivenom (pl)/pg of venom or toxin needed to protect 
half of the injected mice. The ED~ was calculated by the Spearman-Klrber method (WHO, 1981). 
RESULTS 
Dose-response and competition studies 
The binding of AchR to varying amounts of M. n. nigrocinctus venom adsorbed onto 
microtiter wells was tested in a non-radioactive AchR binding assay. A dose-response was 
evident with a maximal absorbance detected in wells coated with 5 ,ug of venom or higher, 
suggesting a saturation of the available binding sites (Fig. 1). Competition for AchR 
1 10 
Venom added (pglwell) 
Fig. 1. Binding of M. n. nigrocincfus a-neurotoxins to AchR. Varying amounts of venom 
(0.1&20 pg) were adsorbed onto microtiter wells followed by the addition of AchR (5 pg/well), 
guinea-pig anti-AchR serum, anti-guinea-pig alkaline phosphatase conjugate, and substrate. 
Control wells containing either PBSG plus receptor or venom without receptor gave absorbance 
readings lower than 0.15. Each point represents the mean f standard deviation (SD.) of four 
determinations. 
Antibodies to Micrurus cc-neurotoxins 373 
1.5 
1.0 
0.5 
0.0 t I c 
.l 1 10 100 
M. n. nigrocicntus venom added t rg/weli ) 
Fig. 2. Binding of Naja naja oxiana NT II to AchR in the presence of varying amounts M. n. 
nigrocinctus venom. 
Microtiter wells were coated with 1 pg of NT II. AchR (5 pg/well) and varying amounts of M. n. 
nigrocinctus venom (0.16-2Opg) were co-incubated 20min before addition to the wells. Bound 
receptor was detected with guinea-pig anti-AchR serum, anti-guinea-pig alkaline phosphatase 
conjugate, and substrate. Control wells containing either PBSG plus receptor or venom without 
receptor gave absorbance readings lower than 0.12. Each point represents the mean rt S.D. of four 
determinations. 
binding between N. n. oxiana neurotoxin II, a short-chain postsynaptic neurotoxin, and 
varying amounts of M. n. njg~ucinctus venom also showed a dose-response (Fig. 2). 
Proteolytic activity was not detected with the amounts of venom used in the AchR assay 
(data not shown), suggesting that inhibition was not due to proteolytic degradation of 
AchR during the assay. 
Inhibition of the binding of M. n. nigrocinctus a-neurotoxins to AchR by specific antibodies 
The ability of sera from horses hyperimmunized against M. nigrocinctus venom to block 
homologous a-neurotoxins binding to AchR was tested in the non-radioactive AchR 
binding assay. Serum samples were obtained from two horses at day 3 1 after the 9th venom 
injection. A concentration-de~ndent inhibition of the binding of M. n. nigrocinct~~ 
a-neurotoxins to AchR by antiserum was observed in preincubation experiments (Fig. 3). 
The antiserum from horse 26 was more potent (ED~" = 3548) than serum from horse 11 
(EDGE = 955) for inhibiting the binding of M. n. nigrocimtus venom to AchR. 
Hyperimmune sera contained antibodies which prevented the binding of M. n. nigrocinc- 
tus a-neurotoxin(s) to AchR in vitro, and also reversed the binding of toxin(s) already 
complexed with the receptor. A concentration-dependent dissociation of the tox- 
in(s)-AchR complex(es) was observed in the presence of antiserum (Fig. 4). Although sera 
from horses 26 and 11 reversed the binding of M. n. nigrocinctus a-neurotoxin(s) to AchR, 
reversal evels were not higher than 43%, even at the lowest dilution of antivenom tested 
(1: 100). 
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Fig. 3. Inhibition of the binding of M. n. nigrocinctus a-neurotoxins to AchR by specific antibodies. 
Microtiter wells were coated with 5 pg of M. n. nigrocinctus venom followed by incubation with 
dilutions of a hyperimmune serum (black bars), sample taken from horse 26 at day 31 after the 
10th venom injection. A non immune serum was used as control (white bars). After a I hr 
incubation at 37°C AchR, guinea-pig anti-AchR serum, conjugate and substrate were sequentially 
added, and the absorbances recorded at 405 nm 30 min later. Results are expressed as a percentage 
of inhibition relative to the absorbances given by wells preincubated with PBSG instead of serum. 
Each bar represents the mean f SD. of three determinations. 
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Fig. 4. Reversal of the binding of M. n. nigrocinctus a-neurotoxins to AchR by specific antibodies. 
Microtiter wells were coated with 5ng of M. n. nigrocinctus venom and incubated with AchR 
(5 pg/well). After removing unbound receptor, wells received dilutions of a hyperimmune serum 
(black bars), sample taken from horse 26 at day 31 after the 10th venom injection. A non immune 
serum was used as control (white bars). After a 30 min incubation at room temperature, guinea-pig 
anti-AchR, serum, conjugate and substrate were sequentially added and the absorbances recorded 
at 405 nm 30 min later. Results are expressed as percentage of reversal, relative to the absorbance 
of wells incubated in parallel with PBSG instead of serum. Each bar represents the mean S.D. f of 
three determinations. 
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Fig. 5. Titrations of a M. n. nigrocinctus equine antivenom against heterologous a-neurotoxins. 
Microtiter wells were each coated with either 1 pg of M. n. nigrocincfus venom or I pg of the 
indicated toxin, and then incubated with different antivenom (batch 207) dilutions. Conjugate and 
then substrate were added and the absorbance readings at 405 nm recorded 30 min later. Each point 
represents the mean of four determinations. Standard deviations were less than 10% and a 
polyvalent Borhrops-Crotalus-Lachrsis antivenom gave readings lower than 0.1 for all toxins at 
all tested dilutions, 
Antibodies in M. nigrocinctus antivenoms cross-react with heterologous cr-neurotoxins 
Antivenom contained antibodies which recognize three short-chain a-neurotoxins (N. n. 
oxiana NT II, Laticauda semifasciata erabutoxin b and N. n. atra cobrotoxin) and one 
long-chain toxin (N. n. oxiana NT I), as evidenced by ELBA (Fig. 5). It was previously 
shown that this antivenom also recognizes in an ELBA two long-chain toxins: B. 
multicinctus a-bungarotoxin and N. n. kaouthia a-cobratoxin, as well as a short-chain 
toxin, N. nigricollis toxin a (Alape-Giron et al., 1994a,b). 
Table 1. ELISA reactivity of different toxins with equine M. nigrocincius antivenom batches 
Antivenom batch 
196 198 207 221 232 
M. n. nigrocinctus wnorn 0.79 * 0.03* 0.98 0.03 k 0.92 0.01 k 1.07 + 0.03 1.13 * 0.04 
Toxins: 
NT II (N.n.0) 0.37 * 0.02 0.49 0.02 * 0.51 0.02 * 0.44 + 0.01 0.53 & 0.02 
Erabutoxin B (L.s) 0.42 0.01 + 0.31 0.01 f 0.25 + 0.01 0.21 * 0.01 0.19 * 0.00 
a-Cobratoxin (N.n.a.) 0.11 *0.01 0.12 0.01 * 0.22 0.01 f 0.16 k 0.01 0.17 & 0.00 
NT I (N.n.o) 0.38 + 0.02 0.31 0.01 * 0.44 0.02 + 0.44 * 0.02 0.44 f 0.02 
a-cobratoxin (NJ&) 0.27 f 0.01 0.27 0.01 + 0.28 0.01 _+ 0.26 + 0.01 0.31 f 0.01 
a-Bungarotoxin (B.m) 0.33 * 0.01 0.17 * 0.01 0.27 + 0.02 0.26 f 0.01 0.34 * 0.02 
Cardiotoxin (N.n.a) (-)t 
;I; 
(-) 
;I; 
(-) 
Cardiotoxin I (N.n.k.) (-) (-) (-) 
*Results correspond to the absorbance values recorded at 405 nm (mean + SD; n = 4). All samples were 
diluted l/200. A polyvalent Borhrop.7, Crotalus, Lachesis antivenom used as control gave absorbances < 0.05 for 
all toxins. 
TAbsorbance < 0.1. 
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Five batches of M. nigrocinctus antivenom were run in parallel to determine interbatch 
variability in antibody cross-reactivity with heterologous a-neurotoxins. All samples were 
diluted 1:200 and absorbance readings taken as an estimate of antibody concentration 
150 - 1:200 1:400 1:800 
Serum dilution 
60 
1 
1:200 1:800 
Serum ditutlon 
I:3200 
Fig. 6. Inhibition of the binding of heterologous cl-neurotoxins to AchR by horse antisera to 
M. n. nigrocinctus venom. 
Naja naja oxiana NT II (A) or Bungurus rnulii~~~c~~ a-bungarotoxi~ (B) were adsorbed onto 
microtiter wells (1 pg/well). Dilutions of N. n. nigrocinctus antivenom were then added (black bars). 
Samples from horse 26 (A) or horse 1 I (B) were used. Samples were taken at day 3 1 after the 10th 
venom injection. A non immune serum was used as a control (white bars). After a 1 hr incubation 
at 37°C AchR, guinea-pig anti-AchR serum, conjugate and substrate were sequentially added and 
the absorbances recorded at 405 nm 30 min later. Results are expressed as percentage of inhibition, 
relative to the absorbances of wells incubated with PBSG instead of serum. Each bar represents 
the mean + SD. of three determinations. 
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against six different a-neurotoxins (Table 1). Cardiotoxins from N. n. kaouthiu and N. n. 
atra venoms were also tested, but did not cross-react with M. nigrocinctus antivenom. 
N. n. oxiuna NT I and II gave the highest absorbance readings among the toxins tested 
(Table 1). 
Ten sera from two horses hyperimmunized against M. nigrocinctus venom had anti- 
bodies that cross-react in ELISA with several cr-neurotoxins. Serum samples were taken 
at different times following venom injections, and run in parallel to determine if there were 
variations in antibody cross-reactivity during immunization (data not shown). An 
interesting difference was observed between both sera: serum from horse 11 showed higher 
reactivity with N. n. oxiana NT I and B. multicinctus a-bungarotoxin than with N. n. oxiana 
NT II, whereas sera from horse 26 showed higher reactivity with N. n. oxiuna neurotoxin 
II relative to the long chain toxins. 
Inhibition of heterologous cr-neurotoxins binding to AchR by M. nigrocinctus antivenoms 
The ability of M. nigrocinctus antivenoms to inhibit the AchR binding of heterologous 
a-neurotoxins was tested in vitro using the non-radioactive AchR binding assay. Serum 
from horse 26 inhibited the binding of N. n. oxiana NT II to AchR in a concentration-de- 
pendent manner (Fig. 6A) with an EDGE of 100. Serum from horse 11 also inhibited 
a-bungarotoxin binding to AchR, but even at the lowest dilution tested (1: 50) the 
inhibition was not higher than 50% (Fig. 6B). Although sera from both horses inhibited 
the binding of heterologous a-neurotoxins to AchR, they did not reverse the binding of 
these toxins already complexed with AchR (data not shown). 
Neutralization studies 
The ability of a M. nigrocinctus antivenom (batch 232) to neutralize the lethal effect of 
M. n. nigrocinctus venom, B. multicinctus cz-bungarotoxin and N. n. oxiana neurotoxin II 
was determined in mice. Four LD~,,S of either venom or the purified toxins caused 
respiratory failure and death of the animals within 2 hr. Antivenom effectively neutralized 
the lethal effects of M. n. nigrocinctus venom (ED,, of 5 ~1 antivenom/pg venom) and 
N. n. oxiuna NT II (ED,, of 240 ~1 antivenom/pg toxin). Mice died at lower antivenom/NT 
II doses, although a concentration-dependent delay in time to death was observed (data 
not shown). In contrast, neither a neutralizing effect nor a delay in time to death was 
observed when antivenom was tested against a -bungarotoxin, even at an antivenom/toxin 
ratio of 96~1 antivenom/pg of toxin. 
DISCUSSION 
Various in vitro methods employing radiolabeled snake venom postsynaptic neurotoxins 
have been used to detect binding to AchR, and study the effects of antitoxins (Charpentier 
et al., 1990; Boulain and MCnez, 1982; Boulain et al., 1982; Pachner and Ricalton, 1989). 
In this study, an ELISA-based, non-radioactive assay was used to detect M. n. nigrocinctus 
venom components which bind to AchR. Although it is well known that Micrurus 
venoms are neurotoxic in uivo, this is the first report of AchR binding activity found in 
one of these venoms. Competition between M. n. nigrocinctus venom and N. n. oxiana NT 
II for binding to AchR was observed, thus indicating that M. n. nigrocinctus venom 
contains a-neurotoxin(s) which specifically bind to AchR. 
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Several M. nigrocinctus antivenom batches and serum samples from horses hyper- 
immunized against crude venom cross-reacted with various elapid short- and long-chain 
cc-neurotoxins. Antisera from horses hy~rimmunized against crude M. nigrocinctus venom 
not only cross-reacted with heterologous ~-neurotoxins, but also inhibited the binding of 
a heterologous short-chain toxin (N. n. oxiuna NT II) and a long-chain toxin (a- 
bungarotoxin) to AchR in vitro. These results suggest he presence of both a-neurotoxin 
types in M. nigrocinctus venom. We have recently isolated four proteins which bind to 
AchR from M. n. nigrocinctus venom; the N-terminal sequences of two revealed identity 
with short-chain cr-neurotoxins whereas two others share N-terminal sequence identity 
with long-chain toxins (Alape-Giron et at., 1995). In addition, M. nigrocinctus antivenom 
also neutralized the lethal effect of N. n. oxiuna NT II in mice, demonstrating that M. n. 
nigrocinctus venom contains short chain a-neurotoxin(s) which share common neutralizing 
epitope(s) with N. n. oxiana NT II. 
Since M. n. nigrocinctus venom also has presynaptic effects (Goularte et al., 1995), the 
question then arises as to the relative importance of ~-neurotoxins in lethality. In the case 
of N. n. siumensis antivenoms, in vivo neutralization correlates well to ELISA titers against 
CX-cobratoxin (Rungsiwongse and Ratanabanangkoon, 1991). If this were the case in 
M. nigrocinctus antivenoms, an ELISA against a-neurotoxin(s) isolated from this venom 
could also be useful to estimate antivenom potency. 
Two different horses hyperimmunized against M. ~~grocinctu~ venom had different 
antibody responses against short- and long-chain M-neurotoxins. This result emphasizes 
the importance of using several animals to prepare therapeutic antisera against snake 
venoms, in order to assure an effective response against various toxin types. Antisera from 
both horses readily inhibited the binding of homologous a-neurotoxin(s) to AchR and also 
reversed the binding of toxin already complexed with receptor. This result supports the 
importance of using antivenom therapeutically even after the onset of neurological 
symptoms. Two neutralizing epitopes have been described in N. nigr~col~is a-toxin: one 
overlaps the AchR binding site and the other is topographically unrelated to the binding 
domain, since it remains accessible after the toxin is bound to AchR (Menez et al., 1992). 
Similar epitopes might also be present on M. n. nigrocinctus a-neurotoxin(s). 
In the preparation of antivenoms, experiments have to be carried out at different time 
points during the immunization schedule to evaluate the development of an antibody 
response, as well as during different stages of the plasma fractionation process. Antivenom 
potency is determined by venom neutralization in a mouse lethality assay. An assessment 
of the ability to inhibit and reverse the binding of a-neurotoxin(s) to AchR, using this 
non-radioactive AchR binding assay, may offer an alternative to estimate the potency of 
M. nigrocinctus antivenoms. Since elapid venoms usually contain several a-neurotoxin 
isoforms (Endo and Tamiya, 1991), the use of crude venom in the assay would be desirable 
for this purpose. A correlation study between the in vivo and in vitro neutralizing 
capabilities of several M. nigrocinctus antivenom preparations is currently underway in our 
laboratories. 
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